Our work focuses on three main categories — immunotherapy, investment and data — with groundbreaking initiatives operating under each. Our unique initiatives are blazing trails in the quest to cure multiple myeloma.
Data

The MMRF CureCloud®
Clinical Acceleration

MMRC
One of our most groundbreaking achievements is the Multiple Myeloma Research Consortium (MMRC), which brings together the best cancer centers in the world to accelerate clinical trials and drive results for patients.